BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29924723)

  • 1. Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation.
    Eftekhari R; de Lima SG; Liu Y; Mihara K; Saifeddine M; Noorbakhsh F; Scarisbrick IA; Hollenberg MD
    Biol Chem; 2018 Sep; 399(9):1023-1039. PubMed ID: 29924723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
    Hansen KK; Oikonomopoulou K; Li Y; Hollenberg MD
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):377-92. PubMed ID: 17952408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation.
    Russell FA; McDougall JJ
    Inflamm Res; 2009 Mar; 58(3):119-26. PubMed ID: 19184346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinases as hormones: targets and mechanisms for proteolytic signaling.
    Hansen KK; Oikonomopoulou K; Baruch A; Ramachandran R; Beck P; Diamandis EP; Hollenberg MD
    Biol Chem; 2008 Aug; 389(8):971-82. PubMed ID: 18979623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase-activated receptors in the lower urinary tract.
    Moffatt JD
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):1-9. PubMed ID: 17294233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSCI/RCPSC Henry Friesen Lecture. Mentors and the butterfly effect: triggers for discovering signalling by proteinases via proteinase-activated receptors (PARs) and more.
    Hollenberg MD
    Clin Invest Med; 2012 Feb; 35(6):E378-91. PubMed ID: 23217564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
    Oikonomopoulou K; Diamandis EP; Hollenberg MD
    Biol Chem; 2010 Apr; 391(4):299-310. PubMed ID: 20180639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.
    Steinhoff M; Buddenkotte J; Shpacovitch V; Rattenholl A; Moormann C; Vergnolle N; Luger TA; Hollenberg MD
    Endocr Rev; 2005 Feb; 26(1):1-43. PubMed ID: 15689571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinases and their receptors in inflammatory arthritis: an overview.
    Oikonomopoulou K; Diamandis EP; Hollenberg MD; Chandran V
    Nat Rev Rheumatol; 2018 Mar; 14(3):170-180. PubMed ID: 29416136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.
    Hollenberg MD; Mihara K; Polley D; Suen JY; Han A; Fairlie DP; Ramachandran R
    Br J Pharmacol; 2014 Mar; 171(5):1180-94. PubMed ID: 24354792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
    Ramachandran R; Hollenberg MD
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.
    Hollenberg MD
    J Pharmacol Sci; 2005 Jan; 97(1):8-13. PubMed ID: 15665444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinases as hormone-like signal messengers.
    Hollenberg MD; Houle S
    Swiss Med Wkly; 2005 Jul; 135(29-30):425-32. PubMed ID: 16208579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.
    Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Diamandis EP; Hollenberg MD
    Biol Chem; 2006 Jun; 387(6):677-85. PubMed ID: 16800728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptors (PARs) and calcium signaling in cancer.
    Kaufmann R; Hollenberg MD
    Adv Exp Med Biol; 2012; 740():979-1000. PubMed ID: 22453980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinase-activated receptors (PARs) in infection and inflammation in the gut.
    Vergnolle N
    Int J Biochem Cell Biol; 2008; 40(6-7):1219-27. PubMed ID: 18313348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation.
    Saban R; D'Andrea MR; Andrade-Gordon P; Derian CK; Dozmorov I; Ihnat MA; Hurst RE; Davis CA; Simpson C; Saban MR
    BMC Physiol; 2007 Mar; 7():4. PubMed ID: 17397548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.
    Hansen KK; Saifeddine M; Hollenberg MD
    Immunology; 2004 Jun; 112(2):183-90. PubMed ID: 15147561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.